High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy
- 12 April 2001
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 755 (1-2) , 151-156
- https://doi.org/10.1016/s0378-4347(01)00059-7
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- High-Performance Liquid Chromatography Method for Analyzing the Antiretroviral Agent Efavirenz in Human PlasmaTherapeutic Drug Monitoring, 1999
- Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- EfavirenzDrugs, 1998